Cannabis for Latent Autoimmune Diabetes

There is currently limited research available on the use of medical cannabis for Latent Autoimmune Diabetes (LADA), a form of diabetes that shares characteristics of both Type 1 and Type 2 diabetes. However, some studies suggest that medical cannabis may help manage symptoms associated with diabetes more broadly, such as inflammation, pain, and neuropathy.

The endocannabinoid system plays a role in regulating various bodily functions, including metabolism and immune response, both of which are affected in diabetes. Cannabinoids found in medical cannabis, such as THC and CBD, interact with the body's endocannabinoid system and may have anti-inflammatory and neuroprotective effects, which could potentially benefit individuals with LADA.

What Studies Exist to Support the Use of Cannabis for Latent Autoimmune Diabetes?

A 2017 study published in the European Journal of Pain found that CBD may reduce pain and improve sleep quality in individuals with chronic pain conditions, including diabetic neuropathy. Another study published in the Journal of Diabetes Research in 2016 found that treatment with a cannabinoid receptor agonist reduced inflammation and improved insulin resistance in obese mice.

Does cannabis for latent autoimmune diabetes have side effects?

The side effects of using medical cannabis for pain, palliative, and cancer care can vary depending on the individual, the method of use, the dosage, and the type of cannabis used. 

It can range from Psychotropic effects like euphoria, drowsiness, dizziness, and confusion to cognitive ones including issues related to memory, attention, and reaction time. Besides, smoking or inhaling cannabis can cause respiratory irritation, coughing, and bronchitis. This can be a concern for patients with preexisting lung conditions.

Cannabis can also cause changes in heart rate and blood pressure, which can be problematic for patients with cardiovascular disease and gastrointestinal discomfort, including nausea, vomiting, and diarrhea.

Key takeaways

• Limited research exists on the use of medical cannabis for Latent Autoimmune Diabetes (LADA), but cannabinoids found in medical cannabis may have anti-inflammatory and neuroprotective effects that could potentially benefit individuals with LADA.

• Studies suggest that medical cannabis may help manage symptoms associated with diabetes more broadly, such as inflammation, pain, and neuropathy.

• However, the side effects of using medical cannabis can vary and may include psychotropic effects, cognitive issues, respiratory irritation, changes in heart rate and blood pressure, and gastrointestinal discomfort.

Please note: More research is needed to fully understand the potential benefits and risks of using medical cannabis for LADA specifically. Individuals with LADA need to consult with a healthcare provider before using medical cannabis as a treatment option for their condition.